首页> 外国专利> METHODS AND COMPOSITIONS FOR TREATING CD33+ CANCERS AND IMPROVING IN VIVO PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR T CELLS

METHODS AND COMPOSITIONS FOR TREATING CD33+ CANCERS AND IMPROVING IN VIVO PERSISTENCE OF CHIMERIC ANTIGEN RECEPTOR T CELLS

机译:治疗CD33 +癌症并改善嵌合抗原受体T细胞体内持久性的方法和组成

摘要

The application relates to a chimeric receptor that targets CD33 and allows activation of the co-stimulatory pathway without binding the natural ligand. The application also relates to polynucleotides that encode the chimeric receptor, vectors, and host cells comprising the chimeric receptor. The application also relates to methods for preparing host cells comprising a chimeric antigen receptor in order to improve the in vivo persistence of the chimeric antigen receptor host cells.
机译:本申请涉及靶向CD33并允许激活共刺激途径而不结合天然配体的嵌合受体。本申请还涉及编码嵌合受体的多核苷酸,载体和包含嵌合受体的宿主细胞。本申请还涉及制备包含嵌合抗原受体的宿主细胞以改善嵌合抗原受体宿主细胞在体内的持久性的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号